CVRx (CVRX) Amortization of Deferred Charges (2020 - 2026)
CVRx's (CVRX) quarterly Amortization of Deferred Charges came in at $83000.0 in Q1 2026, up 40.68% year-on-year from $59000.0 in Q1 2025, and up 36.07% quarter-over-quarter from $61000.0 in Q4 2025.
CVRx (CVRX) Amortization of Deferred Charges (2020 - 2026) Analysis & Trends
CVRx's Amortization of Deferred Charges history runs 7 years deep, the most recent figure standing at $83000.0 for Q1 2026.
- On a quarterly basis, Amortization of Deferred Charges rose 40.68% year-over-year to $83000.0 in Q1 2026; TTM through Mar 2026 was $265000.0, a 23.83% increase from a year earlier, with the FY2025 full-year figure at $241000.0, up 18.72% from the prior year.
- Amortization of Deferred Charges rose to $83000.0 in Q1 2026 per CVRX's latest filing, from $61000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $83000.0 in Q1 2026 and bottomed at $25000.0 in Q4 2022.
- The 5-year median for Amortization of Deferred Charges is $48500.0 (2024), against an average of $50428.6.
- Across the five-year window, Amortization of Deferred Charges jumped 60.0% in 2023 and changed 0.0% in 2025, its largest moves.
- Year by year, Amortization of Deferred Charges stood at $25000.0 in 2022, then jumped by 60.0% to $40000.0 in 2023, then jumped by 52.5% to $61000.0 in 2024, then changed by 0.0% to $61000.0 in 2025, then jumped by 36.07% to $83000.0 in 2026.
- Per Business Quant, the three latest CVRX Amortization of Deferred Charges figures stand at $83000.0 (Q1 2026), $61000.0 (Q4 2025), and $61000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | CVRx | 128.88 Mn | 56.58 Mn | 12.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 83,000.00 |
| Mar 31, 2026 | 83,000.00 |
| Dec 31, 2025 | 61,000.00 |
| Dec 31, 2025 | 61,000.00 |
| Sep 30, 2025 | 61,000.00 |
| Sep 30, 2025 | 61,000.00 |
| Jun 30, 2025 | 60,000.00 |
| Jun 30, 2025 | 60,000.00 |
| Mar 31, 2025 | 59,000.00 |
| Mar 31, 2025 | 59,000.00 |
| Dec 31, 2024 | 61,000.00 |
| Dec 31, 2024 | 61,000.00 |
| Sep 30, 2024 | 45,000.00 |
| Sep 30, 2024 | 45,000.00 |
| Jun 30, 2024 | 49,000.00 |
| Jun 30, 2024 | 49,000.00 |
| Mar 31, 2024 | 48,000.00 |
| Mar 31, 2024 | 48,000.00 |
| Dec 31, 2023 | 40,000.00 |
| Dec 31, 2023 | 40,000.00 |